CDIOW
Cardio Diagnostics Holdings, Inc.
Price Chart
Latest Quote
$0.02
+0.00 (+21.85%)
Current Price
| Previous Close | $0.02 |
| Open | $0.02 |
| Day High | $0.02 |
| Day Low | $0.02 |
| Volume | 460 |
Stock Information
| Total Debt | $533K |
| Cash Equivalents | $7.08M |
| Revenue | $17K |
| Net Income | $-6.65M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $17K |
| Income | $-6.65M |
| Book/sh | $3.01 |
| Employees | 15 |
Financial Ratios
| Quick Ratio | 14.41 |
| Current Ratio | 15.76 |
| Debt/Eq | 5.99 |
Returns & Margins
| ROA | -37.99% |
| ROE | -65.59% |
| Gross Margin | 100.00% |
| Operating Margin | -66598.40% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.01 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| RSI | nan |
| ATR | nan |
| Shares Float | 2.83M |
| Volatility | 2.20 |
| Rel Volume | 20.00 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| YTD | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $nan | 460 |
| 2026-06-12 | $0.03 | 0 |
| 2026-06-11 | $0.03 | 0 |
| 2026-06-10 | $0.03 | 0 |
| 2026-06-09 | $0.03 | 0 |
| 2026-06-08 | $0.03 | 0 |
| 2026-06-05 | $0.03 | 0 |
| 2026-06-04 | $0.03 | 0 |
| 2026-06-03 | $0.03 | 0 |
| 2026-06-02 | $0.03 | 0 |
| 2026-06-01 | $0.03 | 0 |
| 2026-05-29 | $0.03 | 0 |
| 2026-05-28 | $0.03 | 0 |
| 2026-05-27 | $0.03 | 0 |
| 2026-05-26 | $0.03 | 0 |
| 2026-05-22 | $0.03 | 0 |
| 2026-05-21 | $0.03 | 0 |
| 2026-05-20 | $0.03 | 0 |
| 2026-05-19 | $0.03 | 0 |
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
đ° Latest News
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $14,825 | $34,890 | $17,065 | $950 |
| Operating Revenue | $14,825 | $34,890 | $17,065 | $950 |
| Expenses | ||||
| Interest Expense | $14,801 | $18,640 | $6,735,013 | $0 |
| Total Expenses | $6,498,903 | $8,400,767 | $7,259,524 | $4,549,401 |
| Net Non Operating Interest Income Expense | $-14,089 | $-17,576 | $-6,733,945 | $0 |
| Interest Expense Non Operating | $14,801 | $18,640 | $6,735,013 | $0 |
| Operating Expense | $6,498,903 | $8,400,767 | $7,259,524 | $4,549,401 |
| Selling And Marketing Expense | $766,888 | $1,231,969 | $158,514 | $92,700 |
| General And Administrative Expense | $5,025,570 | $6,921,094 | $6,936,646 | $4,400,253 |
| Other Income Expense | - | - | $5,599,570 | $-112,534 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Net Interest Income | $-14,089 | $-17,576 | $-6,733,945 | $0 |
| Interest Income | $712 | $1,064 | $1,068 | $0 |
| Normalized Income | $-6,498,167 | $-8,383,453 | $-13,976,404 | $-4,548,451 |
| Net Income From Continuing And Discontinued Operation | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Total Operating Income As Reported | $-6,484,078 | $-8,365,877 | $-7,242,459 | $-4,548,451 |
| Net Income Common Stockholders | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Net Income | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Net Income Including Noncontrolling Interests | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Net Income Continuous Operations | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Pretax Income | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Interest Income Non Operating | $712 | $1,064 | $1,068 | $0 |
| Operating Income | $-6,484,078 | $-8,365,877 | $-7,242,459 | $-4,548,451 |
| Depreciation Amortization Depletion Income Statement | $65,233 | $19,738 | $19,182 | $16,000 |
| Depreciation And Amortization In Income Statement | $65,233 | $19,738 | $19,182 | $16,000 |
| Amortization Of Intangibles Income Statement | $65,233 | $19,738 | $19,182 | $16,000 |
| Special Income Charges | - | $0 | $193,350 | $-112,534 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,085,238 | $-8,088,468 | $-7,129,771 | $-4,532,451 |
| Reconciled Depreciation | $398,128 | $276,345 | $111,620 | $16,000 |
| EBITDA (Bullshit earnings) | $-6,085,238 | $-8,088,468 | $-1,530,201 | $-4,644,985 |
| EBIT | $-6,483,366 | $-8,364,813 | $-1,641,821 | $-4,660,985 |
| Diluted NI Availto Com Stockholders | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Amortization | $65,233 | $19,738 | $19,182 | $16,000 |
| Research And Development | $641,212 | $227,966 | $145,182 | $40,448 |
| Selling General And Administration | $5,792,458 | $8,153,063 | $7,095,160 | $4,492,953 |
| Other Gand A | $5,025,570 | $6,921,094 | $6,936,646 | $4,400,253 |
| Total Unusual Items | - | $0 | $5,599,570 | $-112,534 |
| Total Unusual Items Excluding Goodwill | - | $0 | $5,599,570 | $-112,534 |
| Other Special Charges | - | - | $-193,350 | - |
| Restructuring And Mergern Acquisition | - | - | $0 | $112,534 |
| Gain On Sale Of Security | - | - | $5,406,220 | - |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,100,172 | $8,851,366 | $2,421,389 | $3,943,067 |
| Total Assets | $7,766,415 | $10,615,312 | $4,462,365 | $6,249,478 |
| Total Non Current Assets | $1,845,712 | $1,824,530 | $1,696,685 | $363,591 |
| Non Current Prepaid Assets | $12,850 | $12,850 | $12,850 | $4,950 |
| Goodwill And Other Intangible Assets | $873,182 | $706,422 | $536,735 | $358,641 |
| Other Intangible Assets | $873,182 | $706,422 | $536,735 | $358,641 |
| Current Assets | $5,920,703 | $8,790,782 | $2,765,680 | $5,885,887 |
| Other Current Assets | $801,947 | $944,683 | $1,477,197 | $1,768,366 |
| Receivables | $8,126 | $18,612 | $4,960 | $0 |
| Accounts Receivable | $8,126 | $18,612 | $4,960 | $0 |
| Cash Cash Equivalents And Short Term Investments | $5,110,630 | $7,827,487 | $1,283,523 | $4,117,521 |
| Cash And Cash Equivalents | $5,110,630 | $7,827,487 | $1,283,523 | $4,117,521 |
| Cash Financial | $5,110,630 | $7,827,487 | $1,283,523 | $4,117,521 |
| Prepaid Assets | - | - | - | $0 |
| Debt | ||||
| Total Debt | $695,619 | $969,863 | $1,261,028 | $849,032 |
| Long Term Debt And Capital Lease Obligation | $188,222 | $425,829 | $663,099 | $0 |
| Current Debt And Capital Lease Obligation | $507,397 | $544,034 | $597,929 | $849,032 |
| Current Debt | $269,790 | $306,764 | $374,000 | $849,032 |
| Other Current Borrowings | $269,790 | $306,764 | $374,000 | $849,032 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $793,061 | $1,057,524 | $1,504,241 | $1,947,770 |
| Total Non Current Liabilities Net Minority Interest | $188,222 | $425,829 | $663,099 | $0 |
| Current Liabilities | $604,839 | $631,695 | $841,142 | $1,947,770 |
| Payables And Accrued Expenses | $97,442 | $87,661 | $243,213 | $1,098,738 |
| Payables | $97,442 | $87,661 | $243,213 | $1,098,738 |
| Accounts Payable | $97,442 | $87,661 | $243,213 | $1,098,738 |
| Other Payable | - | $306,764 | $374,000 | $849,032 |
| Tradeand Other Payables Non Current | - | - | - | $1,098,738 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $6,973,354 | $9,557,788 | $2,958,124 | $4,301,708 |
| Total Equity Gross Minority Interest | $6,973,354 | $9,557,788 | $2,958,124 | $4,301,708 |
| Stockholders Equity | $6,973,354 | $9,557,788 | $2,958,124 | $4,301,708 |
| Retained Earnings | $-29,250,000 | $-22,751,833 | $-14,368,380 | $-5,991,546 |
| Other | ||||
| Ordinary Shares Number | $1,826,051 | $1,531,467 | $684,680 | $317,158 |
| Share Issued | $1,826,051 | $1,531,467 | $684,680 | $317,158 |
| Tangible Book Value | $6,100,172 | $8,851,366 | $2,421,389 | $3,943,067 |
| Invested Capital | $7,243,144 | $9,864,552 | $3,332,124 | $5,150,740 |
| Working Capital | $5,315,864 | $8,159,087 | $1,924,538 | $3,938,117 |
| Capital Lease Obligations | $425,829 | $663,099 | $887,028 | $0 |
| Total Capitalization | $6,973,354 | $9,557,788 | $2,958,124 | $4,301,708 |
| Additional Paid In Capital | $36,223,336 | $32,309,606 | $17,326,299 | $10,293,159 |
| Capital Stock | $18 | $15 | $205 | $95 |
| Common Stock | $18 | $15 | $205 | $95 |
| Long Term Capital Lease Obligation | $188,222 | $425,829 | $663,099 | $0 |
| Current Capital Lease Obligation | $237,607 | $237,270 | $223,929 | $0 |
| Net PPE | $959,680 | $1,105,258 | $1,147,100 | $0 |
| Accumulated Depreciation | $-277,630 | $-117,567 | $-3,790 | $0 |
| Gross PPE | $1,237,310 | $1,222,825 | $1,150,890 | $0 |
| Leases | $502,155 | $502,155 | $482,170 | $0 |
| Other Properties | $590,052 | $602,820 | $575,227 | - |
| Machinery Furniture Equipment | $145,103 | $117,850 | $93,493 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Preferred Stock | - | $0 | $0 | $0 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-6,146,143 | $-5,397,294 | $-6,466,466 | $-5,167,122 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,726,833 | $-4,993,104 | $-5,672,175 | $-5,090,968 |
| Cash Flow From Continuing Operating Activities | $-5,726,833 | $-4,993,104 | $-5,672,175 | $-5,090,968 |
| Operating Gains Losses | - | - | $-5,599,570 | - |
| Investing Activities | ||||
| Capital Expenditure | $-419,310 | $-404,190 | $-794,291 | $-76,154 |
| Investing Cash Flow | $-419,310 | $-404,190 | $-794,291 | $-368,001 |
| Cash Flow From Continuing Investing Activities | $-419,310 | $-404,190 | $-794,291 | $-368,001 |
| Net Other Investing Changes | - | - | $-21,352 | $-433,334 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $3,803,498 | $12,391,949 | $0 | $11,986,036 |
| Financing Cash Flow | $3,429,286 | $11,941,258 | $3,632,468 | $9,063,723 |
| Cash Flow From Continuing Financing Activities | $3,429,286 | $11,941,258 | $3,632,468 | $9,063,723 |
| Net Other Financing Charges | $-374,212 | $-450,691 | $-1,257,532 | $-2,922,313 |
| Net Common Stock Issuance | $3,803,498 | $12,391,949 | $0 | $11,986,036 |
| Common Stock Issuance | $3,803,498 | $12,391,949 | $0 | $11,986,036 |
| Other | ||||
| Interest Paid Supplemental Data | $14,801 | $18,640 | $30,491 | $5,829 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | - |
| End Cash Position | $5,110,630 | $7,827,487 | $1,283,523 | $4,117,521 |
| Beginning Cash Position | $7,827,487 | $1,283,523 | $4,117,521 | $512,767 |
| Changes In Cash | $-2,716,857 | $6,543,964 | $-2,833,998 | $3,604,754 |
| Net Intangibles Purchase And Sale | $-231,993 | $-189,425 | $-197,276 | $-76,154 |
| Purchase Of Intangibles | $-231,993 | $-189,425 | $-197,276 | $-76,154 |
| Net PPE Purchase And Sale | $-187,317 | $-214,765 | $-597,015 | $0 |
| Purchase Of PPE | $-187,317 | $-214,765 | $-597,015 | $0 |
| Change In Working Capital | $262,971 | $522,836 | $208,814 | $-558,517 |
| Change In Other Current Liabilities | $-237,270 | $-223,929 | $244,505 | $0 |
| Change In Payables And Accrued Expense | $9,781 | $-155,552 | $-781,500 | $136,353 |
| Change In Prepaid Assets | $479,974 | $915,969 | $750,769 | $-695,771 |
| Change In Receivables | $10,486 | $-13,652 | $-4,960 | $901 |
| Changes In Account Receivables | $10,486 | $-13,652 | $-4,960 | $901 |
| Stock Based Compensation | $110,235 | $2,591,168 | $1,279,273 | $0 |
| Depreciation Amortization Depletion | $398,128 | $276,345 | $111,620 | $16,000 |
| Depreciation And Amortization | $398,128 | $276,345 | $111,620 | $16,000 |
| Amortization Cash Flow | $238,065 | $162,568 | $107,830 | $16,000 |
| Amortization Of Intangibles | $238,065 | $162,568 | $107,830 | $16,000 |
| Depreciation | $160,063 | $113,777 | $3,790 | $0 |
| Net Income From Continuing Operations | $-6,498,167 | $-8,383,453 | $-8,376,834 | $-4,660,985 |
| Issuance Of Debt | - | $0 | $4,500,000 | $0 |
| Proceeds From Stock Option Exercised | - | $0 | $390,000 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $4,500,000 | $0 |
| Net Long Term Debt Issuance | - | $0 | $4,500,000 | $0 |
| Long Term Debt Issuance | - | $0 | $4,500,000 | $0 |
| Net Business Purchase And Sale | - | - | $0 | $141,487 |
| Sale Of Business | - | - | $0 | $141,487 |
| Other Non Cash Items | - | - | $6,704,522 | $112,534 |
| Gain Loss On Investment Securities | - | - | $-5,406,220 | - |
| Purchase Of Business | - | - | - | $0 |
Fetched: 2026-06-15